Published: Fri, November 16, 2018
Health Care | By Cedric Leonard

Blood pressure medication recalled for impurity that might cause cancer

Blood pressure medication recalled for impurity that might cause cancer

The FDA recently recalled blood pressure drug irbesartan for the same defect.

FDA recall on Losartan, a popular blood pressure medication. As per the FDA, the latest recall has impacted less than 1% of the total products of losartan drug all over the U.S. market. FDA said they found some contamination: N-nitrosodiethylamine (NDEA) in some of these drugs and that's they have recalled them to prevent any further consumption of these contaminated drugs. The impurity, known as NDEA, was found in the drug's key ingredient made by Zhejiang Huahai Pharmaceutical Co.in China. They come in 1000-count plastic bottles labeled NDC 0781-5207-10 with a lot number of JB8912. This product was distributed nationwide to distributors after October 8.

The impurity, according to an FDA statement, occurs naturally in certain foods, drinking water, air pollution, and industrial processes and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC). Date 06/2020. This product was distributed nationwide to distributors. Many more were announced in August as the recall spread to Canada and the European Union.

Wayne Rooney: Callum Wilson, Jadon Sancho hail England 'legend'
England manager Gareth Southgate said he was pleased with his team's display and with the send-off for Rooney. "We are delighted to have him with us".


Sandoz has notified distributors and patients in a letter of the recall.

According to the FDA, Losartan Potassium-Hydrochlorothiazide Tablets, USP are indicated for the treatment of hypertension.

For any questions, call Sandoz at 1-800-525-8747 Monday through Friday, 8:30 a.m.to 5 p.m. Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them.

Like this: